Methods of treating diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies

The present invention relates to methods of treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment a composition comprising an interleukin-13 (IL-13) antibody or an antigen-binding fragmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GULATI SHILPA, PIETSCH ROBERT, TIMONY, G, RARD
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GULATI SHILPA
PIETSCH ROBERT
TIMONY, G
RARD
description The present invention relates to methods of treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment a composition comprising an interleukin-13 (IL-13) antibody or an antigen-binding fragment thereof. 本发明涉及通过给需要这种治疗的主体施用含有白介素-13(IL-13)抗体或其抗原结合片段的组合物来治疗IL-13活性在其中有害的疾病(包括嗜酸性粒细胞性食管炎(EoE)和哮喘)的方法。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN114617962A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN114617962A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN114617962A3</originalsourceid><addsrcrecordid>eNqNi0EKwjAQAHPxIOof1gfkECsVj1IUBfXkPazN1izUpHRXxd-r0Ad4mjnMjI0_kcYcBHID2hMqpxsEFkIhAU7wilxHOBytKwBr5SfrG1ggkPZ8p6TYwkN-FyZlO4RfvebAJFMzarAVmg2cmPlue6n2lrrsSTqsKZH66uzcsnSrdbnYFP80H7U9O2E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods of treating diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies</title><source>esp@cenet</source><creator>GULATI SHILPA ; PIETSCH ROBERT ; TIMONY, G ; RARD</creator><creatorcontrib>GULATI SHILPA ; PIETSCH ROBERT ; TIMONY, G ; RARD</creatorcontrib><description>The present invention relates to methods of treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment a composition comprising an interleukin-13 (IL-13) antibody or an antigen-binding fragment thereof. 本发明涉及通过给需要这种治疗的主体施用含有白介素-13(IL-13)抗体或其抗原结合片段的组合物来治疗IL-13活性在其中有害的疾病(包括嗜酸性粒细胞性食管炎(EoE)和哮喘)的方法。</description><language>chi ; eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220614&amp;DB=EPODOC&amp;CC=CN&amp;NR=114617962A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220614&amp;DB=EPODOC&amp;CC=CN&amp;NR=114617962A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GULATI SHILPA</creatorcontrib><creatorcontrib>PIETSCH ROBERT</creatorcontrib><creatorcontrib>TIMONY, G</creatorcontrib><creatorcontrib>RARD</creatorcontrib><title>Methods of treating diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies</title><description>The present invention relates to methods of treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment a composition comprising an interleukin-13 (IL-13) antibody or an antigen-binding fragment thereof. 本发明涉及通过给需要这种治疗的主体施用含有白介素-13(IL-13)抗体或其抗原结合片段的组合物来治疗IL-13活性在其中有害的疾病(包括嗜酸性粒细胞性食管炎(EoE)和哮喘)的方法。</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0EKwjAQAHPxIOof1gfkECsVj1IUBfXkPazN1izUpHRXxd-r0Ad4mjnMjI0_kcYcBHID2hMqpxsEFkIhAU7wilxHOBytKwBr5SfrG1ggkPZ8p6TYwkN-FyZlO4RfvebAJFMzarAVmg2cmPlue6n2lrrsSTqsKZH66uzcsnSrdbnYFP80H7U9O2E</recordid><startdate>20220614</startdate><enddate>20220614</enddate><creator>GULATI SHILPA</creator><creator>PIETSCH ROBERT</creator><creator>TIMONY, G</creator><creator>RARD</creator><scope>EVB</scope></search><sort><creationdate>20220614</creationdate><title>Methods of treating diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies</title><author>GULATI SHILPA ; PIETSCH ROBERT ; TIMONY, G ; RARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN114617962A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GULATI SHILPA</creatorcontrib><creatorcontrib>PIETSCH ROBERT</creatorcontrib><creatorcontrib>TIMONY, G</creatorcontrib><creatorcontrib>RARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GULATI SHILPA</au><au>PIETSCH ROBERT</au><au>TIMONY, G</au><au>RARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods of treating diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies</title><date>2022-06-14</date><risdate>2022</risdate><abstract>The present invention relates to methods of treating diseases in which IL-13 activity is detrimental, including eosinophilic esophagitis (EoE) and asthma, by administering to a subject in need of such treatment a composition comprising an interleukin-13 (IL-13) antibody or an antigen-binding fragment thereof. 本发明涉及通过给需要这种治疗的主体施用含有白介素-13(IL-13)抗体或其抗原结合片段的组合物来治疗IL-13活性在其中有害的疾病(包括嗜酸性粒细胞性食管炎(EoE)和哮喘)的方法。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN114617962A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Methods of treating diseases in which IL-13 activity is detrimental using anti-IL-13 antibodies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A25%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GULATI%20SHILPA&rft.date=2022-06-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN114617962A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true